UBC researchers are the first in the world to publish structural images of the N501Y mutation on the SARS-CoV-2 spike protein—a change believed to be partly responsible for the highly… Read More
VANCOUVER, BC– NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical-stage biotech company dedicated to developing innovative treatments for nerve damage and neurodegenerative diseases, is pleased… Read More
THOUSAND OAKS, Calif., May 5, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for Otezla® (apremilast) for the treatment of adults… Read More
A national study has concluded that pregnant women are more likely to become severely ill from the COVID 19 virus. As a result, pregnant women are now being given priority… Read More
Human Factors discovery, innovation, and regulatory compliance are crucial to delivering a successful medical device. On May 11th, 2021, 10:00 AM PDT, four human factor experts will present lessons learned,… Read More
